VarCov Co’s Privia Health PRVA Stock Holding History

VarCov Co’s Portfolio PRVA Stock Details PRVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.51M	Buy	58,732 +25,080	+75%	+$581K	0.57%	42
2026 Q1	$692K	Buy	+33,652	New	+$759K	0.26%	145

Other funds holding PRVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

VarCov Co's PRVA Position: Q2 2026 in Review

VarCov Co increased its Privia Health (PRVA) stake by 75% in Q2 2026, buying an estimated $581K and bringing the position to 58,732 shares worth $1.51M. The position accounts for 0.57% of the portfolio, ranked #42.

VarCov Co first reported a position in PRVA in Q1 2026 and has held it in 2 quarters since. 300 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

VarCov Co held 58,732 shares of Privia Health worth $1.51M as of Q2 2026.
VarCov Co bought 25,080 Privia Health shares in Q2 2026, an estimated $581K.
Privia Health made up 0.57% of VarCov Co's portfolio in Q2 2026, its #42 holding.
VarCov Co first reported a position in Privia Health in Q1 2026 and has held it in 2 quarters since.
300 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on VarCov Co's 13F filing for Q2 2026, filed 14 Aug 2026.